- 関
- matrix metalloproteinase 13
WordNet
- the 13th letter of the Roman alphabet (同)m
PrepTutorEJDIC
- Mach number / mark[s] / Monsieur
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/12/17 05:33:01」(JST)
[Wiki en表示]
Matrix metallopeptidase 13 (collagenase 3) |
PDB rendering based on 1cxv. |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1EUB, 1FLS, 1FM1, 1PEX, 1XUC, 1XUD, 1XUR, 1YOU, 1ZTQ, 2D1N, 2E2D, 2OW9, 2OZR, 2PJT, 2YIG, 3ELM, 3I7G, 3I7I, 3KEC, 3KEJ, 3KEK, 3KRY, 3LJZ, 3O2X, 3TVC, 3ZXH, 456C, 4A7B, 4FU4, 4FVL, 4G0D, 830C
|
|
|
Identifiers |
Symbols |
MMP13; CLG3; MANDP1 |
External IDs |
OMIM: 600108 MGI: 1340026 HomoloGene: 20548 ChEMBL: 280 GeneCards: MMP13 Gene |
EC number |
3.4.24.- |
Gene Ontology |
Molecular function |
• metalloendopeptidase activity
• calcium ion binding
• zinc ion binding
|
Cellular component |
• extracellular region
• proteinaceous extracellular matrix
• extracellular space
|
Biological process |
• proteolysis
• extracellular matrix disassembly
• extracellular matrix organization
• bone mineralization
• collagen catabolic process
• cellular protein metabolic process
• cartilage development
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
4322 |
17386 |
|
Ensembl |
ENSG00000137745 |
ENSMUSG00000050578 |
|
UniProt |
P45452 |
P33435 |
|
RefSeq (mRNA) |
NM_002427 |
NM_008607 |
|
RefSeq (protein) |
NP_002418 |
NP_032633 |
|
Location (UCSC) |
Chr 11:
102.81 – 102.83 Mb |
Chr 9:
7.27 – 7.28 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Collagenase 3 is an enzyme that in humans is encoded by the MMP13 gene.[1][2] It is a member of the matrix metalloproteinase (MMP) family. Like most MMPs, it is secreted as an inactive pro-form. It is activated once the pro-domain is cleaved, leaving an active enzyme composed of the catalytic domain and the hemopexin-like domain PDB 1PEX. Although the actual mechanism has not been described, the hemopexin domain participates in collagen degradation, the catalytic domain alone being particularly inefficient in collagen degradation. During embryonic development, MMP13 is expressed in the skeleton as required for restructuring the collagen matrix for bone mineralization. In pathological situations it is highly overexpressed; this occurs in human carcinomas, rheumatoid arthritis and osteoarthritis.[3]
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The protein encoded by this gene cleaves type II collagen more efficiently than types I and III. It may be involved in articular cartilage turnover and cartilage pathophysiology associated with osteoarthritis. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3.[2]
References[edit]
- ^ Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C (Jul 1994). "Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas". J Biol Chem 269 (24): 16766–73. PMID 8207000.
- ^ a b "Entrez Gene: MMP13 matrix metallopeptidase 13 (collagenase 3)".
- ^ Johansson N, Ahonen M, Kähäri VM. (2000). "Matrix metalloproteinases in tumor invasion.". Cell Mol Life Sci. 57 (1): 5–15. PMID 10949577.
Further reading[edit]
- Nagase H, Woessner JF (1999). "Matrix metalloproteinases.". J. Biol. Chem. 274 (31): 21491–4. doi:10.1074/jbc.274.31.21491. PMID 10419448.
- Leeman MF, Curran S, Murray GI (2003). "The structure, regulation, and function of human matrix metalloproteinase-13.". Crit. Rev. Biochem. Mol. Biol. 37 (3): 149–66. doi:10.1080/10409230290771483. PMID 12139441.
- Pendás AM, Matilla T, Estivill X, López-Otín C (1995). "The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family.". Genomics 26 (3): 615–8. doi:10.1016/0888-7543(95)80186-P. PMID 7607691.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Mitchell PG, Magna HA, Reeves LM, et al. (1996). "Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.". J. Clin. Invest. 97 (3): 761–8. doi:10.1172/JCI118475. PMC 507114. PMID 8609233.
- Knäuper V, Will H, López-Otin C, et al. (1996). "Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.". J. Biol. Chem. 271 (29): 17124–31. doi:10.1074/jbc.271.29.17124. PMID 8663255.
- Gomis-Rüth FX, Gohlke U, Betz M, et al. (1997). "The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain.". J. Mol. Biol. 264 (3): 556–66. doi:10.1006/jmbi.1996.0661. PMID 8969305.
- Knäuper V, Cowell S, Smith B, et al. (1997). "The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.". J. Biol. Chem. 272 (12): 7608–16. doi:10.1074/jbc.272.12.7608. PMID 9065415.
- Pendás AM, Balbín M, Llano E, et al. (1997). "Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13).". Genomics 40 (2): 222–33. doi:10.1006/geno.1996.4554. PMID 9119388.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Willmroth F, Peter HH, Conca W (1998). "A matrix metalloproteinase gene expressed in human T lymphocytes is identical with collagenase 3 from breast carcinomas.". Immunobiology 198 (4): 375–84. PMID 9562863.
- Lovejoy B, Welch AR, Carr S, et al. (1999). "Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.". Nat. Struct. Biol. 6 (3): 217–21. doi:10.1038/6657. PMID 10074939.
- Barmina OY, Walling HW, Fiacco GJ, et al. (1999). "Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization.". J. Biol. Chem. 274 (42): 30087–93. doi:10.1074/jbc.274.42.30087. PMID 10514495.
- Lauer-Fields JL, Tuzinski KA, Shimokawa K, et al. (2000). "Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.". J. Biol. Chem. 275 (18): 13282–90. doi:10.1074/jbc.275.18.13282. PMID 10788434.
- Hiller O, Lichte A, Oberpichler A, et al. (2000). "Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.". J. Biol. Chem. 275 (42): 33008–13. doi:10.1074/jbc.M001836200. PMID 10930399.
- McQuibban GA, Gong JH, Tam EM, et al. (2000). "Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.". Science 289 (5482): 1202–6. doi:10.1126/science.289.5482.1202. PMID 10947989.
- Terp GE, Christensen IT, Jørgensen FS (2000). "Structural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexes.". J. Biomol. Struct. Dyn. 17 (6): 933–46. doi:10.1080/07391102.2000.10506582. PMID 10949161.
- Nakamura H, Fujii Y, Inoki I, et al. (2001). "Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.". J. Biol. Chem. 275 (49): 38885–90. doi:10.1074/jbc.M003875200. PMID 10986281.
External links[edit]
- The MEROPS online database for peptidases and their inhibitors: M10.013
PDB gallery
|
|
|
1cxv: STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13)
|
|
1eub: SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR
|
|
1fls: SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
|
|
1fm1: SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
|
|
1pex: COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN
|
|
1xuc: Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
|
|
1xud: Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
|
|
1xur: Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
|
|
1you: Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibitor
|
|
1ztq: Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033
|
|
2d1n: Collagenase-3 (MMP-13) complexed to a hydroxamic acid inhibitor
|
|
2e2d: Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2
|
|
2ow9: Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor
|
|
456c: CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
|
|
830c: COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID
|
|
|
|
Proteases: metalloendopeptidases (EC 3.4.24)
|
|
ADAM proteins |
- Alpha secretases
- ADAM9
- ADAM10
- ADAM17
- ADAM19
- ADAM2
- ADAM7
- ADAM8
- ADAM11
- ADAM12
- ADAM15
- ADAM18
- ADAM22
- ADAM23
- ADAM28
- ADAM33
- ADAMTS1
- ADAMTS2
- ADAMTS3
- ADAMTS4
- ADAMTS5
- ADAMTS8
- ADAMTS9
- ADAMTS10
- ADAMTS12
- ADAMTS13
|
|
Matrix metalloproteinases |
- Collagenases
- Gelatinases
- MMP3
- MMP7
- MMP10
- MMP11
- MMP12
- MMP13
- MMP14
- MMP15
- MMP16
- MMP17
- MMP19
- MMP20
- MMP21
- MMP23A
- MMP23B
- MMP24
- MMP25
- MMP26
- MMP27
- MMP28
|
|
Other |
- Neprilysin
- Procollagen peptidase
- Thermolysin
- Pregnancy-associated plasma protein A
- Bone morphogenetic protein 1
- Lysostaphin
- Insulin degrading enzyme
- ZMPSTE24
|
|
- B
- enzm
- 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice.
- Matsuzaki T, Matsushita T, Takayama K, Matsumoto T, Nishida K, Kuroda R, Kurosaka M.
- Annals of the rheumatic diseases.Ann Rheum Dis.2014 Jul;73(7):1397-404. doi: 10.1136/annrheumdis-2012-202620. Epub 2013 May 30.
- OBJECTIVES: Important roles for SIRT1 are implicated in ageing and age-related diseases. The role of SIRT1 in osteoarthritis (OA), however, remains partially unknown. To investigate the role of SIRT1 in chondrocytes in vivo, cartilage-specific Sirt1-conditional knockout (CKO) mice were analysed usin
- PMID 23723318
- Chondroprotective and anti-inflammatory effects of S-methylisothiourea, an inducible nitric oxide synthase inhibitor in cartilage and synovial explants model of osteoarthritis.
- Balaganur V1, Pathak NN, Lingaraju MC, More AS, Latief N, Kumari RR, Kumar D, Tandan SK.
- The Journal of pharmacy and pharmacology.J Pharm Pharmacol.2014 Jul;66(7):1021-31. doi: 10.1111/jphp.12228. Epub 2014 Feb 20.
- OBJECTIVES: To study the chondroprotective and anti-inflammatory potential of inducible nitric oxide synthase (iNOS) inhibitor S-methylisothiourea (SMT) in in-vitro model.METHODS: Rabbit cartilage explants were stimulated with recombinant human interleukin 1β (rhIL-1β), and the chondroprotective a
- PMID 24697299
- Protection of ginsenoside Rg1 on chondrocyte from IL-1β-induced mitochondria-activated apoptosis through PI3K/Akt signaling.
- Huang Y1, Wu D, Fan W.
- Molecular and cellular biochemistry.Mol Cell Biochem.2014 Jul;392(1-2):249-57. doi: 10.1007/s11010-014-2035-1. Epub 2014 Mar 27.
- Chondrocyte apoptosis is closely related to the development and progression of osteoarthritis. Ginsenoside Rg1 protects cells by antagonizing apoptosis. This study aimed to investigate the protective effect of Rg1 on interleukin 1β (IL-1β)-induced chondrocyte apoptosis and the underlying molecular
- PMID 24671491
Japanese Journal
- P8-003 ブレオマイシン誘発強皮症モデルマウスの線維化,血管障害および免疫異常の病態における転写因子IRF5の役割についての検討
- 三枝 良輔,浅野 善英,谷口 隆志,市村 洋平,高橋 岳浩,遠山 哲夫,吉崎 歩,佐藤 伸一
- 日本臨床免疫学会会誌 37(4), 367a-367a, 2014
- … (線維化,血管障害,炎症・免疫異常)におけるIRF5の役割について検討した.Irf5−/−マウスの無刺激状態の皮膚では,野生型マウスに比べ細いcollagen線維束が目立ち,type I collagenの発現低下およびMMP-13の発現亢進がみられた.さらに,lumican, lysyl oxidase, ADAMTS2といったfibrillogenesisに関与する分子の発現低下がみられた.また,BLM投与による皮膚硬化および肺線維化がIrf5−/−マウスで抑制されていた …
- NAID 130004694301
- Type II collagen peptide stimulates Akt leading to nuclear factor-κB activation: Its inhibition by hyaluronan
- Biomedical Research 35(3), 193-199, 2014
- … While nuclear factor (NF)-κB is a critical pathway for matrix metalloproteinase (MMP)-13 inductionin chondrocytes, intracellular upstream events for NF-κB activation by the type II collagenpeptide (CB12-II) with catabolic activities remain unclear. … In monolayer cultures, pretreatmentwith HA of 2700 kDa significantly inhibited MMP-13 production by CB12-II-stimulatedchondrocytes. …
- NAID 130004470867
- CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Has Anti-Aging Effects That Protect Articular Cartilage from Age-Related Degenerative Changes
- Itoh Shinsuke,Hattori Takako,Tomita Nao,Aoyama Eriko,Yutani Yasutaka,Yamashiro Takashi,Takigawa Masaharu
- PLoS ONE 8(8), 2013-08-12
- … Transgenic articular cartilage showed enhanced toluidine blue and safranin-O staining as well as chondrocyte proliferation but reduced staining for type X and I collagen and MMP-13 as compared with those parameters for WT cartilage. … CTS applied to primary cultures of mock-transfected rib chondrocytes from WT cartilage and WT epiphyseal cartilage induced expression of Col1a1, ColXa1, Mmp-13, and Mmp-9 mRNAs; …
- NAID 120005345531
Related Links
- リコンビナント ヒトMMP-8,13 MMP-13(Collagenase3)は最近新しく発見されたメタロプロテアーゼの1つで、腫瘍、骨関節炎患者の軟骨、リウマチ患者の滑膜、さらには創傷部位などの色々な組織中に認められています。
- 1)抗ヒトMMP-13抗体固相化マイクロタイタープレート 2)アッセイ緩衝液(濃縮液) 3)ヒトMMP-13標準 4)HRP(Horseradish peroxidase)標識抗ヒトMMP-13抗体 5)洗浄液 6)基質溶液(TMB : tetramethylbenzidine) 保存温度-15 ...
Related Pictures
★リンクテーブル★
[★]
マトリックスメタロプロテアーゼ13
- 関
- MMP-13
[★]
- 英
- matrix metalloproteinase 13、MMP-13
[★]
[★]
マトリックスメタロプロテアーゼ matrix metalloproteinase
[★]
マトリックスメタロプロテアーゼ
[★]
メチオニン methionine